Avg target $300.50+121.3%Median $300.00High $330.00Low $279.008 targets in the last 12 months
Price vs average target
Revenue and EPS estimates
Consensus estimates
Fiscal period
FY2025Dec '25
FY2026Dec '26
FY2027Dec '27
FY2028Dec '28
Revenue (B)
0.51
0.89
2.85
7.54
Growth YoY
–
+73.6%
+221.9%
+164.7%
High estimate
0.61
0.89
3.05
9.90
Low estimate
0.46
0.89
2.63
6.70
Analysts
5
7
8
10
EPS, adjusted
1.64
−0.52
1.24
7.97
Growth YoY
–
−131.7%
n/m
+542.8%
High estimate
2.08
−0.16
1.50
14.81
Low estimate
1.45
−1.00
1.00
4.55
Analysts
3
6
6
4
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
Brokers
10 firms active in the last 12 months
Firm
Analyst
Rating
Prev rating
Target
Prev target
Chg
Upside
Date
Freedom Capital Markets
–
Buy
Hold
–
–
–
–
Oct 2
Needham
–
Buy
Buy
$300.00
–
–
+121%
Aug 19
Rosenblatt
Kevin Cassidy
Buy
Buy
$300.00
–
–
+121%
Aug 19
Citigroup
–
Buy
Buy
–
–
–
–
Aug 13
Mizuho
–
Outperform
Outperform
$310.00
$300.00
+3%
+128%
Aug 13
Morgan Stanley
Joseph Moore
Overweight
Overweight
$279.00
$273.00
+2%
+105%
Aug 13
UBS
–
Buy
Buy
$330.00
$320.00
+3%
+143%
Aug 13
Wedbush
–
Outperform
Outperform
$280.00
$270.00
+4%
+106%
Aug 13
Barclays
Tom O'Malley
–
–
$280.00
–
–
+106%
Jun 8
Craig-Hallum
–
–
–
$325.00
–
–
+139%
Jun 8
Latest analyst action · Page refreshed hourly; analyst feeds refreshed daily · About this data